- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
CM Management LLC Sells 120,000 Shares of ClearPoint Neuro, Inc.
The investment firm reduced its stake in the medical technology company by 60%.
Published on Mar. 8, 2026
Got story updates? Submit your updates here. ›
CM Management LLC, an investment firm, has reduced its holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) by 60% in the third quarter, according to a recent SEC filing. The firm sold 120,000 shares of the medical technology company, leaving it with 80,000 shares, or approximately 0.28% ownership stake.
Why it matters
The sale by CM Management LLC is noteworthy as it represents a significant reduction in the firm's position in ClearPoint Neuro. The medical technology company develops and commercializes an MRI-guided therapy platform for minimally invasive neurosurgical procedures, which could indicate a shift in investor sentiment or portfolio strategy.
The details
According to the 13F filing, CM Management LLC sold 120,000 shares of ClearPoint Neuro during the third quarter, reducing its stake in the company by 60%. The investment firm now owns 80,000 shares, valued at approximately $1.7 million as of the most recent SEC filing.
- CM Management LLC sold the 120,000 shares of ClearPoint Neuro in the 3rd quarter of the year.
The players
CM Management LLC
An investment firm that has reduced its stake in ClearPoint Neuro, Inc. by 60% in the third quarter.
ClearPoint Neuro, Inc.
A medical technology company that develops and commercializes an MRI-guided therapy platform for minimally invasive neurosurgical procedures.
The takeaway
The sale by CM Management LLC suggests a potential shift in investor sentiment or portfolio strategy regarding ClearPoint Neuro, a company that develops innovative medical technology for neurosurgical procedures. This development could signal broader market trends or changes in the medical device industry that investors should monitor.
